Cargando…
Self-driving laboratories: A paradigm shift in nanomedicine development
Nanomedicines have transformed promising therapeutic agents into clinically approved medicines with optimal safety and efficacy profiles. This is exemplified by the mRNA vaccines against COVID-19, which were made possible by lipid nanoparticle technology. Despite the success of nanomedicines to date...
Autores principales: | Hickman, Riley J., Bannigan, Pauric, Bao, Zeqing, Aspuru-Guzik, Alán, Allen, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993483/ https://www.ncbi.nlm.nih.gov/pubmed/37020832 http://dx.doi.org/10.1016/j.matt.2023.02.007 |
Ejemplares similares
-
Shifting the Paradigm on Cannabis Safety
por: Bannigan, Pauric, et al.
Publicado: (2022) -
Machine learning models to accelerate the design of polymeric long-acting injectables
por: Bannigan, Pauric, et al.
Publicado: (2023) -
Data evaluating triamcinolone acetonide and triamcinolone hexacetonide loaded poly(δ-valerolactone-co-allyl-δ-valerolactone) microparticles
por: Bao, Zeqing, et al.
Publicado: (2023) -
Heat-activated nanomedicine formulation improves the anticancer potential of the HSP90 inhibitor luminespib in vitro
por: Epp-Ducharme, Brittany, et al.
Publicado: (2021) -
Chimera: enabling hierarchy based multi-objective optimization for self-driving laboratories
por: Häse, Florian, et al.
Publicado: (2018)